Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Animal Parasiticide Market , by Product Types (Ectoparasiticides [Pour On, Spot On, Sprays], Endoparasiticides [Injectable, Oral], Endectocides), Animal Type (Farm Animals, Companion Animals), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026

  • RES4072047
  • 110 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
The animal parasiticide market forecast will be $7,082.2 million by 2026, and is rising from $5,096.0 million in 2018, at a growth rate of 4.2%.

Market Definition:

Animal parasiticides are chemical substances used in veterinary medicine to destroy parasites that infest animals and livestock. The use of animal parasiticides and their derivatives in treatment of animals and livestock has resulted in the development of the health. Endectocides, endoparasiticides and ectoparasiticides are considered the key type of animal parasiticides.

Market Drivers:

Animal Parasiticide industry insights

Important animal parasiticide market drivers including upsurge in adoption of pet animals’ owners and rapid growth in demand for livestock protein across the world. This is due to rise in the number of veterinary consultants and upsurge in the requirement for livestock derived foods, that will further boost the growth of the animal parasiticide industry. Growing occurrence of zoonotic infections has stimulated demand for parasiticide products to control or prevent disease occurrence. Furthermore, increasing consciousness about animal zoonotic diseases, concerns of the livestock health and upsurge in the pet owning is rising the parasiticide market. These aspects will enhance the animal parasiticide market growth over forecast timeframe. Furthermore, upsurge in the requirement of the parasiticide product for the livestock food protein will increase the use of parasiticide and their derivatives, that include injections and medicines through controlling parasite infestation. Increasing usage of antiparasitics for improved and better treatment in animals is expected to drive the growth of animal parasiticide market in the future time.

Market Restraints:

Huge cost associated with antiparasitics products and lack of availability of the raw materials for the production of parasiticide products is estimated to restraint the growth of the animal parasiticide market.

Market Opportunities:

Growing the incidences of the zoonotic diseases in the livestock and animals support the growth of the animal parasiticide market in projected time.

The global animal parasiticide market is classified on the basis of product type and animal type. Based on product type, the market is further classified into ectoparasiticides, endoparasiticides and endectocides. The endectocides product market has registered for key market size and is accounted for $2,293.2 million in 2018, is estimated to generate $3,109.1 million, growing at a 3.9% CAGR during projected period. Ectoparasiticides market will witness a noteworthy growth during forecast period, it is estimated to reach $1,678.5 million by the end of 2026.

The market for farm animals type was dominated in 2018, generating a revenue of $3,465.3 million and is estimated to grow $4,759.3 million by the end of 2026. This growth is contributed to growing requirement of healthy meat and livestock food protein. The companion animals type market will experience noteworthy growth, which is projected to generate a revenue of $2,323.0, at a 4.5% CAGR, owing to rise in the pet owning across the world.

The global animal parasiticide market share dominated by North America in 2018, it has registered a revenue of $1,885.5 million and is anticipated to generate $2,556.7 million by the end of 2026. This growth attributed to upsurge in the pet animals’ adaption rate across the region. Asia-Pacific market is estimated to experience a notable growth during the forecast period. This is owing to increase in the requirement of the livestock food and derived product in Asia-Pacific countries, due to this Asia-Pacific market is expected to generate a revenue of $1,614.8 million by the end of 2026.

The animal parasiticide market players are Boehringer Ingelheim animal Health, Eli Lilly, Vetoquinol, Elanco, Bayer AG, Perrigo Company Plc, Sanofi, Ceva Santé Animale, Merck Co., and Zoetis Inc., These companies are concentrating on product advancements, R&D investments, geographical expansions and partnerships are the major tactics to gain majority of the market share in the overall industry.

1. Research Methodology

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.4.1. Assumptions

1.4.2. Forecast parameters

1.5. Data sources

1.5.1. Primary

1.5.2. Secondary

2. Executive Summary

2.1. 360° summary

2.2. Product Type trends

2.3. Animal Type trends

3. Market overview

3.1. Market segmentation & definitions

3.2. Key takeaways

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of consumers

3.3.2. Bargaining power of suppliers

3.3.3. Threat of new entrants

3.3.4. Threat of substitutes

3.3.5. Competitive rivalry in the market

3.4. Market dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.5. Technology landscape

3.6. Regulatory landscape

3.7. Patent landscape

3.8. Pricing overview

3.8.1. By product type

3.8.2. By animal type

3.8.3. By region

3.9. Market value chain analysis

3.9.1. Stress point analysis

3.9.2. Raw material analysis

3.9.3. Manufacturing process

3.9.4. Distribution channel analysis

3.9.5. Operating vendors

3.9.5.1. Raw material suppliers

3.9.5.2. Product manufacturers

3.9.5.3. Product distributors

3.10. Strategic overview

4. Animal Parasiticide Market, by Product Type

4.1. Ectoparasiticides

4.1.1. Market size and forecast, by region, 2018-2026

4.1.2. Comparative market share analysis, 2018 & 2026

4.1.3. Pour On

4.1.3.1. Market size and forecast, by region, 2018-2026

4.1.3.2. Comparative market share analysis, 2018 & 2026

4.1.4. Spot On

4.1.4.1. Market size and forecast, by region, 2018-2026

4.1.4.2. Comparative market share analysis, 2018 & 2026

4.1.5. Sprays

4.1.5.1. Market size and forecast, by region, 2018-2026

4.1.5.2. Comparative market share analysis, 2018 & 2026

4.2. Endoparasiticides

4.2.1. Market size and forecast, by region, 2018-2026

4.2.2. Comparative market share analysis, 2018 & 2026

4.2.3. Injectables

4.2.3.1. Market size and forecast, by region, 2018-2026

4.2.3.2. Comparative market share analysis, 2018 & 2026

4.2.4. Oral

4.2.4.1. Market size and forecast, by region, 2018-2026

4.2.4.2. Comparative market share analysis, 2018 & 2026

4.2.4.3. Liquids

4.2.4.3.1. Market size and forecast, by region, 2018-2026

4.2.4.3.2. Comparative market share analysis, 2018 & 2026

4.2.4.4. Tablets

4.2.4.4.1. Market size and forecast, by region, 2018-2026

4.2.4.4.2. Comparative market share analysis, 2018 & 2026

4.3. Endectocides

4.3.1.1. Market size and forecast, by region, 2018-2026

4.3.1.2. Comparative market share analysis, 2018 & 2026

4.4. Others

4.4.1. Market size and forecast, by region, 2018-2026

4.4.2. Comparative market share analysis, 2018 & 2026

5. Animal Parasiticide s Market, by Animal Type

5.1. Farm animals

5.1.1. Market size and forecast, by region, 2018-2026

5.1.2. Comparative market share analysis, 2018 & 2026

5.2. Companion animals

5.2.1. Market size and forecast, by region, 2018-2026

5.2.2. Comparative market share analysis, 2018 & 2026

6. Animal Parasiticide s Market, by Region

6.1. North America

6.1.1. Market size and forecast, by product type, 2018-2026

6.1.2. Market size and forecast, by animal type, 2018-2026

6.1.3. Market size and forecast, by country, 2018-2026

6.1.4. Comparative market share analysis, 2018 & 2026

6.1.5. U.S.

6.1.5.1. Market size and forecast, by product type, 2018-2026

6.1.5.2. Market size and forecast, by animal type, 2018-2026

6.1.5.3. Comparative market share analysis, 2018 & 2026

6.1.6. Canada

6.1.6.1. Market size and forecast, by product type, 2018-2026

6.1.6.2. Market size and forecast, by animal type, 2018-2026

6.1.6.3. Comparative market share analysis, 2018 & 2026

6.2. Europe

6.2.1. Market size and forecast, by product type, 2018-2026

6.2.2. Market size and forecast, by animal type, 2018-2026

6.2.3. Market size and forecast, by country, 2018-2026

6.2.4. Comparative market share analysis, 2018 & 2026

6.2.5. Germany

6.2.5.1. Market size and forecast, by product type, 2018-2026

6.2.5.2. Market size and forecast, by animal type, 2018-2026

6.2.5.3. Comparative market share analysis, 2018 & 2026

6.2.6. UK

6.2.6.1. Market size and forecast, by product type, 2018-2026

6.2.6.2. Market size and forecast, by animal type, 2018-2026

6.2.6.3. Comparative market share analysis, 2018 & 2026

6.2.7. France

6.2.7.1. Market size and forecast, by product type, 2018-2026

6.2.7.2. Market size and forecast, by animal type, 2018-2026

6.2.7.3. Comparative market share analysis, 2018 & 2026

6.2.8. Spain

6.2.8.1. Market size and forecast, by product type, 2018-2026

6.2.8.2. Market size and forecast, by animal type, 2018-2026

6.2.8.3. Comparative market share analysis, 2018 & 2026

6.2.9. Italy

6.2.9.1. Market size and forecast, by product type, 2018-2026

6.2.9.2. Market size and forecast, by animal type, 2018-2026

6.2.9.3. Comparative market share analysis, 2018 & 2026

6.2.10. Rest of Europe

6.2.10.1. Market size and forecast, by product type, 2018-2026

6.2.10.2. Market size and forecast, by animal type, 2018-2026

6.2.10.3. Comparative market share analysis, 2018 & 2026

6.3. Asia Pacific

6.3.1. Market size and forecast, by product type, 2018-2026

6.3.2. Market size and forecast, by animal type, 2018-2026

6.3.3. Market size and forecast, by country, 2018-2026

6.3.4. Comparative market share analysis, 2018 & 2026

6.3.5. China

6.3.5.1. Market size and forecast, by product type, 2018-2026

6.3.5.2. Market size and forecast, by animal type, 2018-2026

6.3.5.3. Comparative market share analysis, 2018 & 2026

6.3.6. India

6.3.6.1. Market size and forecast, by product type, 2018-2026

6.3.6.2. Market size and forecast, by animal type, 2018-2026

6.3.6.3. Comparative market share analysis, 2018 & 2026

6.3.7. Australia

6.3.7.1. Market size and forecast, by product type, 2018-2026

6.3.7.2. Market size and forecast, by animal type, 2018-2026

6.3.7.3. Comparative market share analysis, 2018 & 2026

6.3.8. Rest of Asia Pacific

6.3.8.1. Market size and forecast, by product type, 2018-2026

6.3.8.2. Market size and forecast, by animal type, 2018-2026

6.3.8.3. Comparative market share analysis, 2018 & 2026

6.4. LAMEA

6.4.1. Market size and forecast, by product type, 2018-2026

6.4.2. Market size and forecast, by animal type, 2018-2026

6.4.3. Market size and forecast, by country, 2018-2026

6.4.4. Comparative market share analysis, 2018 & 2026

6.4.5. Latin America

6.4.5.1. Market size and forecast, by product type, 2018-2026

6.4.5.2. Market size and forecast, by animal type, 2018-2026

6.4.5.3. Comparative market share analysis, 2018 & 2026

6.4.6. Middle East

6.4.6.1. Market size and forecast, by product type, 2018-2026

6.4.6.2. Market size and forecast, by animal type, 2018-2026

6.4.6.3. Comparative market share analysis, 2018 & 2026

6.4.7. Africa

6.4.7.1. Market size and forecast, by product type, 2018-2026

6.4.7.2. Market size and forecast, by animal type, 2018-2026

6.4.7.3. Comparative market share analysis, 2018 & 2026

7. Company profiles

7.1. Sanofi

7.1.1. Business overview

7.1.2. Financial performance

7.1.3. Product portfolio

7.1.4. Recent strategic moves & developments

7.1.5. SWOT analysis

7.2. Zoetis Inc.

7.2.1. Business overview

7.2.2. Financial performance

7.2.3. Product portfolio

7.2.4. Recent strategic moves & developments

7.2.5. SWOT analysis

7.3. Eli Lilly

7.3.1. Business overview

7.3.2. Financial performance

7.3.3. Product portfolio

7.3.4. Recent strategic moves & developments

7.3.5. SWOT analysis

7.4. Elanco

7.4.1. Business overview

7.4.2. Financial performance

7.4.3. Product portfolio

7.4.4. Recent strategic moves & developments

7.4.5. SWOT analysis

7.5. Ceva Santé Animale

7.5.1. Business overview

7.5.2. Financial performance

7.5.3. Product portfolio

7.5.4. Recent strategic moves & developments

7.5.5. SWOT analysis

7.6. Perrigo Company Plc

7.6.1. Business overview

7.6.2. Financial performance

7.6.3. Product portfolio

7.6.4. Recent strategic moves & developments

7.6.5. SWOT analysis

7.7. Boehringer Ingelheim animal Health

7.7.1. Business overview

7.7.2. Financial performance

7.7.3. Product portfolio

7.7.4. Recent strategic moves & developments

7.7.5. SWOT analysis

7.8. Merck Co.

7.8.1. Business overview

7.8.2. Financial performance

7.8.3. Product portfolio

7.8.4. Recent strategic moves & developments

7.8.5. SWOT analysis

7.9. Vetoquinol

7.9.1. Business overview

7.9.2. Financial performance

7.9.3. Product portfolio

7.9.4. Recent strategic moves & developments

7.9.5. SWOT analysis

7.10. Bayer AG

7.10.1. Business overview

7.10.2. Financial performance

7.10.3. Product portfolio

7.10.4. Recent strategic moves & developments

7.10.5. SWOT analysis

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research